期刊文献+

香加皮三萜类化合物对甲基苄基亚硝胺诱导的食管癌大鼠调节性T细胞功能的影响 被引量:2

Effects of triterpenes compound of cortex periplocae on regulatory T cells function in N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats
下载PDF
导出
摘要 目的:探讨香加皮三萜类化合物(triterpenes compound of cortex periplocae,TCCP)对甲基苄基亚硝胺(N_nitrosomethylbenzylamine,NMBA)诱导的食管癌大鼠CD4+CD25+调节性T细胞功能的影响。方法:健康雄性F344大鼠40只,随机分为模型组(0.5mg/kg NMBA皮下注射)、治疗组(0.5mg/kg NMBA皮下注射及10mg/kg TCCP肌肉注射)、大豆油对照组(肌肉注射大豆油1ml/kg)和正常对照组,每组10只。各组每周给受试物3次,连续5周。分别在给受试物后第9周和第15周抽取4组大鼠外周血各1ml。用流式细胞仪检测大鼠外周血中CD4+T细胞和CD4+CD25+调节性T细胞(Tr细胞)的水平。另留取血清用ELISA法检测大鼠外周血白细胞介素IL_2、IL_10和转化生长因子TGF_β1的含量。结果:与正常对照组相比,NMBA给药后第9周和第15周,模型组外周血中CD4+T细胞比例均显著降低(P均<0.05),而CD4+CD25+Tr细胞比例均显著升高(P均<0.05)。与同时期模型组比较,TCCP治疗组在给药后第9周和第15周外周血中CD4+T细胞比例升高,CD4+CD25+Tr细胞比例降低,差异均具有统计学意义(P均<0.05)。NMBA给药后第9周和第15周,模型组大鼠外周血中IL-10、TGF-β1水平显著高于正常对照组(P均<0.05),经TCCP治疗后显著下降(P均<0.05);大鼠外周血中IL-2水平则呈现与之相反的趋势。结论:NMBA诱导大鼠食管癌后外周血中CD4+CD25+Tr细胞水平增加,TCCP可以通过抑制CD4+CD25+Tr细胞活化来纠正食管癌发生、发展过程中所致免疫细胞抑制状态,改善NMBA诱导的食管癌大鼠细胞免疫功能紊乱。 OBJECTIVE:To investigate the effects of triterpenes compound of cortex periplocae(TCCP)on CD4^+ CD25^+ regulatory T cells in peripherial blood in N-nitrosomethylbenzylamine(NMBA)-induced esophageal tumorigenesis in F344 rats.METHODS:40 male F344 rats(5-6 weeks of age)were randomly divided into four groups:rats were treated with 0.5 mg/kg NMBA only as model group and rats received NMBA 0.5 mg/kg s.c.plus TCCP 10 mg/kg i.m.as TCCP treatment groups and those treated with soya oil 1 ml/kg intramuscularily(i.m.)acted as soya oil control and normal control groups.10 rats in each group were treated thrice per week for 5 weeks.Then the numbers of CD4^+ and CD4^+CD25^+ regulatory T cells in peripheral blood were counted by flow cytometry at weeks 9 and 15.The levels of IL-2,IL-10 and TGF-β1 in peripheral blood were detected with ELISA.RESULTS:After 0.5 mg/kg NMBA treatment for 9 weeks,CD4^+ T cells in peripheral blood of NMBA group rats were decreased significantly whilst CD4^+CD25^+ regulatory T cells were significantly increased compared with the control group(P0.05).At weeks 9 and 15,TCCP treatment decreased the proportions of CD4^+CD25^+ regulatory T cells,while the proportions of CD4^+ cells were significantly increased(P0.05),compared with NMBA group.At week 9 after NMBA treatment,the protein levels of TGF-β1 and IL-10 in peripheral blood were significantly higher than those in normal control group and soya controlgroup.However the protein levels of IL-2 were significantly decreased,as compared with normal control.TCCP could decrease the expression of IL-10 and TGF-β1,but increase the expression of IL-2.CONCLUSION:In rats the expression of CD4^+CD25^+ regulatory T cells in peripheral blood were enhanced after treatment with NMBA,while the triterpenes compound of Cortex Periplocae effectively inhibited the expression,thus it could improve the immune dysfunction in experimental esophageal tumorigenesis in F344 rats.
出处 《癌变.畸变.突变》 CAS CSCD 2010年第3期206-209,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 国家自然科学基金(30772752) 河北省自然科学基金(C2008000952)
关键词 香加皮三萜类化合物 甲基苄基亚硝胺 食管癌 调节性T细胞 triterpenes compound of cortex periplocae N-nitrosomethylbenzylamine esophageal neoplasms regulatory T cell
  • 相关文献

参考文献14

  • 1Bach JF.Regulatory T cells under scrutiny[J].Nat Rev Immunol,2003,3(3):189-198.
  • 2Von Boehmer H.Mechanisms of suppression by suppressor T cells[J].Nat Immunol,2005,6 (4):338-344.
  • 3张静,单保恩,张超,赵瑞撵,李启亮,刘江惠,李巧敏,李润青.香加皮羽扇豆烷乙酸酯(CPLA)对树突状细胞分化成熟的影响[J].细胞与分子免疫学杂志,2006,22(1):26-28. 被引量:14
  • 4Tong Chen,Hyejeong Hwang,Miranda E,et al.Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis:downregulation of cyclooxygenase-2,inducible nitric oxide synthase,and c-jun[J].Cancer Res,2006,66(5):2853-2859.
  • 5Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995,155(3):1151.
  • 6Stoop JN,van der Molen RG,Baan CC,et al.Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection[J].Hepatology,2005,41(4):771-778.
  • 7Terabe M,Berzofsky JA.Immunoregulatory T cells in tumor immunity[J].Curr Opin Immunol,2004,16(2):157-162.
  • 8Maloy KJ,Salaun L,Cahill R,et al.CD4^+CD25^+T (R) cells suppress innate immune pathology through cytokinedependent mechanismsfj].J Exp Med,2003,197(1):111-119.
  • 9Masaki H,Cherry IK,Masanori N,et al.IL-10 is required for regulatory T cells to mediate tolerance to alloantigen in vivo[J].J Immunol,2001,166(9):3789-3796.
  • 10Yamagiwa S,Gray J,Hashimoto S,et al.A role for TGF-β in the generation and expansion of CD4^+CD25^+ regulatory T cells from human peripheral blood[J].Immunol,2001,166 (12):728-729.

二级参考文献9

  • 1陈月,陈政良,左大明,裘毅刚,张丽芸.MBL对树突状细胞体外分化成熟的影响[J].细胞与分子免疫学杂志,2005,21(2):159-162. 被引量:11
  • 2Schuler G,Steinman RM.Dendritic cells as adjuvants for immune mediated resistance to tumors[J].J Exp Med,1997,186(8):1183-1187.
  • 3Brunner C,Seiderer J,Schlamp A,et al.Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo[J].J Immunol,2000,165(11):6278-6286.
  • 4Pillarisetty VG,Miller G,Shah AB,et al.GM-CSF expands dendritic cells and their progenitors in mouse liver[J].Hepatolopy,2003,37(3):641-652.
  • 5Lutz MB,Schuler G.Immature,semi-mature and fully mature dendritic cells:which signals induce tolerance or immunity?[J].Trends Immunol,2002,23(9):445-449.
  • 6Jin Y,Fuller L,Ciancio G,et al.Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow[J].Hum Immunol,2004,65(2):93-103.
  • 7Banchereau J,Steinman RM.Dendritic cells and the control of immunity[J].Nature,1998,392(6673):245-252.
  • 8Rouard H,Leon A,Klonjkowski B,et al.Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity[J].J Immunol Methods,2000,241(1-2):69-81.
  • 9Inaba K,Witmer-Pack M,Inaba M,et al.The tissue distribution of the B7-2 costimulator in mice:abundant expression on dendritic cells in situ and during maturation in vitro[J].J Exp Med,1994,180(5):1849-1860.

共引文献28

同被引文献30

  • 1刘莉,姚军霞,丁乾,黄士昂.非霍奇金淋巴瘤患者外周血CD4^+CD25^(high)调节性T细胞研究[J].中国实验血液学杂志,2006,14(1):119-122. 被引量:30
  • 2张静,单保恩,刘刚叁,赵学涛,陈书红.香加皮提取物抗肿瘤活性的研究[J].癌变.畸变.突变,2006,18(2):108-111. 被引量:21
  • 3Yang ZZ, Novak AJ, StensonMJ, et M. Intratumoral CD4+ CD25+regulatory T cellmediated suppression of infilitrating CD4+ T cell in B -cell non - Hodgkin lymphoma [J]. Blood, 2006,107 (9): 3639.
  • 4Miller AM, Lundberg K, zenciV, etal. CD4+CD25 high TceUs are enriched in the tumor and peripheral blood of prostate cancer patients [J]. Immunol, 2006, 177 (10): 7398-7405.
  • 5Zou W.Regulatory T cells, tumour immunity and immunotherapy [J]. Nat Revlmmunol, 2006, 6 (4): 295-307.
  • 6Enarsson K, Lundgren A, Kindlund B, et al. Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma [J]. Clinlmmunol, 2006, 121 (3): 358-368.
  • 7Gao Q, Qiu SJ, Fan J, etal. Imratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocel- lular carcinoma after resection [J]. Clin Oncol, 2007, 25 (18): 2586-2593.
  • 8Visser J, Nijman HW, Hoogenboom BN, eta1. Frequencies and role ofregulatory T cells in patients with (pre) malignant cervical neoplasia [J]. Clin Exp Immunol, 2007, 150 (2): 199.
  • 9Baecher-Allan C, Anderson DE. Regulatory cells and human cancer [J]. SeminCancerBiol, 2006, 16 (2): 98-105.
  • 10Kono K, Kawaida H, Takahashi A, et al. CD4~CD25high regulatory T cells increase with tumor stage in patients with gas- tric and esophageal cancers [J]. Cancer Immunol Immunother, 2006, 55 (9): 1064-1071.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部